This deals with a subject of great relevance for malaria control in Africa, the need to increase access to anti-malarial treatment through community health works and home-treatment.
Paper comparing different diagnostic methods used in Nigeria, from a cost-effectiveness view point .
The authors present important and original in-depth information on the reasons for use and non-use of ITNs. Such information is timely and of relevance to malaria control programmes throughout the region.
This preliminary study suggests that this specific mutant MSP119 27+31+34+43, which also abrogates the binding of all known blocking monoclonal antibodies without affecting the processing-inhibitory antibody epitope, might be a better choice for an MSP1-based malaria vaccine.
The SD FK80 P.f/P.v Malaria Antigen Rapid Test (Standard Diagnostics, Korea) (FK80) is a three-band malaria rapid diagnostic test detecting Plasmodium falciparum histidine-rich protein-2 (HRP-2) and Plasmodium vivax-specific lactate dehydrogenase (Pv-pLDH). The present study assessed its performance in a non-endemic setting.
Whether different endogenous protein expression levels of Epo or differences in the abundance of its receptor components could account for the extent of structural neuropathological changes or neurological complications in adults with severe malaria was investigated.
This study aimed to determine the feasibility and impact of training rural drug vendors on community-based malaria treatment and advice with referral of severe cases to a health facility.
This study was conducted to estimate intra-population genetic diversity, genetic differentiation and demographic history of An. albimanus populations because knowledge of vector population structure is a useful tool to guide malaria control programmes.
This study reports the impact of HIV-1 infection and other variables on the level of malaria humoral immunity in adults with clinical malaria and whether humoral immune suppression was a risk factor for treatment failure.
Different techniques used to measure compliance were compared among children treated by the anti-malarial amodiaquine/sulphadoxine-pyrimethamine (AQ/SP) combination therapy, in use in Senegal between 2004 and 2006.